Case study review of a new gelling foam dressing in the management of 14 Diabetic Foot Ulcerations.
Introduction
Management of diabetic foot ulcers presents a major clinical challenge.
In 2007 a gelling foam dressing* was added to the wound care formulary at a district general teaching hospital in theUK . The aim of the review is to illustrate the effective use of the new gelling foam dressing* in the management of 14 diabetic foot ulcers.
Method.
Retrospectively 14 case notes were reviewed [12 male & 2 female; age 44-86yrs (mean age 65)] who had attended one of the podiatry ulcer clinics. Ulcer duration before dressings commenced 1 week – 12 weeks (mean duration 5 weeks).
Following holistic and local wound symptom assessment 14 ulcerations were selected for use of the new gelling foam dressing.
Wound symptoms included: peri-wound maceration, moderate to heavy exudate, clinical signs of infection and/or the presence of slough. Each ulcer was classified using Texas wound classification system (Armstrong et al 1998) and re dressed twice weekly.
A clinical decision was made to use an antimicrobial hydrofiber dressing** if clinical signs of infection were displayed.
Results.
Outcomes were positive: 12 of the 14 ulcerations remained healed. One patient re-ulcerated three weeks later and one patient died.
Discussion.
Although it is not possible to demonstrate this dressing regime alone led to the ulcerations healing, The application of a gelling foam dressing combined with an antimicrobial hydrofiber dressing when required, promoted positive and good clinical outcomes for these patients.
®/TM The following are trade marks of ConvaTec Ltd
* Versiva® XC™
** Aquacel Ag®
Introduction
Management of diabetic foot ulcers presents a major clinical challenge.
In 2007 a gelling foam dressing* was added to the wound care formulary at a district general teaching hospital in the
Method.
Retrospectively 14 case notes were reviewed [12 male & 2 female; age 44-86yrs (mean age 65)] who had attended one of the podiatry ulcer clinics. Ulcer duration before dressings commenced 1 week – 12 weeks (mean duration 5 weeks).
Following holistic and local wound symptom assessment 14 ulcerations were selected for use of the new gelling foam dressing.
Wound symptoms included: peri-wound maceration, moderate to heavy exudate, clinical signs of infection and/or the presence of slough. Each ulcer was classified using Texas wound classification system (Armstrong et al 1998) and re dressed twice weekly.
A clinical decision was made to use an antimicrobial hydrofiber dressing** if clinical signs of infection were displayed.
Results.
Ulcer location. | Numbers | Classification | Ulcer duration (wks) & referral source | Outcome - time to heal (wks) |
Patients | 14 | |||
Digit dorsal aspect or apex | III I | BI B2 DI D2 | 3/52 self treatment | 7/52 20/52 12/52 32/52 |
Heel Ulcer | I I I | CI CI D2 | 8/52 nurses 10/52 nurses 7/52 GP | 22/52 24/52 21/52 |
Interdigital ulcer | I I | DI D2 | 4/52 podiatry 4/52 podiatry | 7/52 8/52 |
Plantar ulceration | I I I | BI AI B3 | 3/52 self treatment 4/52 podiatry 12/52 podiatry | died 7/52 3/52 (reulcerated) |
Discussion.
Although it is not possible to demonstrate this dressing regime alone led to the ulcerations healing, The application of a gelling foam dressing combined with an antimicrobial hydrofiber dressing when required, promoted positive and good clinical outcomes for these patients.
®/TM The following are trade marks of ConvaTec Ltd
* Versiva® XC™
** Aquacel Ag®